Systemic Vitamin D Supplementation in Dental Implants Patients (VitaminD)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02582892|
Recruitment Status : Completed
First Posted : October 21, 2015
Last Update Posted : October 22, 2015
|Condition or disease||Intervention/treatment||Phase|
|Osteoporosis||Drug: Vit D||Phase 4|
Evidence has demonstrated that vitamin D deficiency plays an important role in dental implants outcomes.
Low serum levels of Vitamin D is considered as a risk factor, not only for low mineral bone density but also in other metabolic pathways such as those involved in immune response and chronic inflammatory diseases.
There are few studies demonstrating the role that vitamin D deficiency in the etiopathogenesis of oral diseases and the consequences in Dental Implants.
Dentists have not yet well understood the importance of a good bone metabolism response for a successful bone regeneration and osseointegration of implants.
An insufficient bone response can not guarantee the necessary stability of the implants placed in it, has been one of the biggest problems of implantology.
Thus, the aim of this study is to evaluate the efficacy of Systemic vitamin D supplementation in menopausal women cadidates for dental implants.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||135 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Systemic Vitamin D Supplementation in Menopausal Women With Dental Implants|
|Study Start Date :||October 2012|
|Actual Primary Completion Date :||October 2013|
|Actual Study Completion Date :||October 2015|
Vit D 20 mg/day
Drug: Vit D
Other Name: Vitamin D
- 25 OH Serum levels [ Time Frame: 2 years ]VIT D Serum levels
- Osteoporosis condition [ Time Frame: 2 years ]Densitometry in patients femur bones
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02582892
|Fortaleza, CE, Brazil, 60115-191|
|Natal, RN, Brazil, 59060|
|Sao Paulo, Brazil, 04023-062|
|Study Chair:||Gugliemo G Campus, PhD||Università degli Studi di Sassari|